|
Home : Unsafe Drugs : Avandia : Newsfeeds : Oman: Ban clamped on diabetes drug Oman: Ban clamped on diabetes drug
MUSCAT: Avandia (Rosiglitazone Maleate), the anti-diabetes drug produced by GlaxoSmithKline GlaxoSmithKline ( GSK GSK ), has been withdrawn from the Omani market. The registration of the drug has also been "suspended" in the Sultanate and the doctors and ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




